Miss. Code. tit. 15, pt. 2, subpt. 11, ch. 1, subch. 19, Appendices to the Rules and Regulations Governing Reportable Diseases and Conditions, app 15-2-11-1-19-B
Laboratories shall report these findings to the Mississippi State Department of Health at least WEEKLY. Diseases in bold type shall be reported immediately by telephone. Isolates of organisms marked with a dagger ([DAGGER]) shall be sent to the Mississippi State Department of Health Public Health Laboratory. All referring laboratories should call the Public Health Laboratory prior to shipping any isolate (601-576-7582).
Positive Bacterial Cultures or Direct Examinations
Result | Reportable Disease |
Any bacterial agent in CSF | Bacterial meningitis |
Bacillus anthracis[DAGGER] | Anthrax |
Bordetella pertussis | Pertussis |
Borrelia burgdorferi[DAGGER] | Lyme disease |
Brucella species[DAGGER] | Brucellosis |
Burkholderia mallei[DAGGER] | Glanders |
Burkholderia pseudomallei[DAGGER] | Melioidosis |
Campylobacter species | Campylobacteriosis |
Carbapenem-resistant Enterobacteriaceae | Carbapenem-resistant Enterobacteriaceae (CRE) |
Chlamydia psittaci | Psittacosis |
Chlamydia trachomatis | Chlamydia trachomatis genital infection |
Clostridium botulinum[DAGGER]** | Botulism |
Clostridium tetani | Tetanus |
Corynebacterium diphtheriae[DAGGER] | Diphtheria |
Coxiella bumetii[DAGGER] | Q fever |
Enterococcus species * vancomycin resistant | Enterococcus infection, invasive vancomycin resistant |
Escherichia coli 0157:H7 and any shiga toxin-producing | Escherichia coli 0157:H7 and any shiga toxin- |
E. coli (STEC[DAGGER] | producing E. coli (STEC) |
Francisella tularensis[DAGGER] | Tularemia |
Grimontia hollisaef[DAGGER] | Noncholera Vibrio disease |
Haemophilus ducreyi | Chancroid |
Haemophilus influenza [DAGGER]*( not from throat, sputum) | H. influenzae infection, invasive |
Legionella species | Legionellosis |
Listeria monosytogenes[DAGGER] | Listeriosis |
Mycobacterium species | Nontuberculous mycobacterial disease |
Mycobacterium tuberculosis[DAGGER] | Tuberculosis |
Neisseria gonorrhea | Gonorrhea |
Neisseria meningitidis [DAGGER]* | Meningococcal infection, invasive |
Photobacterium damselae[DAGGER] | Noncholera Vibrio disease |
Rickettsia prowazekii | Typhus fever |
Rickettsia rickettsii | Rocky Mountain spotted fever |
Salmonella species, not S. typhi[DAGGER] | Salmonellosis |
Salmonella typhi[DAGGER] | Typhoid fever |
Shigella species[DAGGER] | Shigellosis |
Staphylococcus aureus- vancomycin resistant or | Staphylococcus aureus vancomycin resistant (VRSA) or |
vancomycin intermediate resistant | vancomycin intermediate (VISA) |
Streptococcus pneumoniae *[DOUBLE DAGGER] | Streptococcus pneumoniae, invasive infection |
Vibrio cholerae 01[DAGGER] | Cholera |
Vibrio species[DAGGER] | Noncholera Vibrio disease |
Yersinia pestis[DAGGER] | Plague |
* Specimen obtained from a normally sterile site (usually blood or cerebrospinal fluid, or, less commonly, joint, pleural, or pericardial fluid). Do not report throat or sputum isolates.
[DAGGER] Isolates of organism should be sent to the Mississippi State Department of Health Public Health Laboratory. All referring laboratories should call the Public Health Laboratory at (601)-576-7582 prior to shipping any isolate.
[DOUBLE DAGGER] Isolates should be sent to the Mississippi State Department of Health Public Health Laboratory for specimens obtained from a normally sterile site in patients 12 years of age.
**Contact the Mississippi State Department of Health, Epidemiology Program at 601-576-7725 or the Public Health Laboratory (601)576-7582 for appropriate tests when considering a diagnosis of botulism.
Laboratory Results That Must be Reported to the Mississippi State Department of Health
Laboratories shall report these findings to the Mississippi State Department of Health at least WEEKLY. Diseases in bold type shall be reported immediately by telephone. Confirmatory tests for some of these may be obtained by special arrangement through the Epidemiology Program at 601-576-7725.
Positive Serologic Tests
Arboviral agents including but not limited to:
California encephalitis
Chikungunya virus
Dengue
Eastern equine encephalitis
LaCrosse encephalitis
St. Louis encephalitis
Western equine encephalitis
West Nile encephalitis
Zika virus
Brucellosis
Chagas Disease (American trypanosomiasis)
Cholera
Chlamydia trachomatis genital infection
Ehrlichiosis
Hepatitis A (anti-HAV IgM)
Hepatitis B (anti-HBcIgM)
Hepatitis B (HBsAg) in pregnancy
Hepatitis C
HIV infection
Legionellosis§
Lyme disease
Malaria
Measles
Mumps
M. tuberculosis infection
Plague
Poliomyelitis
Psittacosis
Rocky Mountain Spotted Fever
Rubella
SARS-CoV-2 (all laboratory results)
Syphilis
Smallpox
Trichinosis
Varicella infection, primary in patients > 15 years of age
Yellow fever
§ Serologic confirmation of an acute case of Legionellosis cannot be based on a single titer.
There must be a four-fold rise in titer to >1:128 between acute and convalescent specimens.
Laboratory Results That Must beReported to the Mississippi State Department of Health
Laboratories shall report these findings to the Mississippi State Department of Health at least WEEKLY. Diseases in bold type shall be reported immediately by telephone. The dagger [DAGGER] indicates the positive specimens may be submitted to the Mississippi Public Health Laboratory for confirmation.
Positive Parasitic Cultures or Direct Examinations | |
Result | Reportable Disease Condition |
Any parasite in CSF[DAGGER] | Parasitic meningitis |
Cryptosporidium parvum | Cryptosporidiosis |
Trypanosoma cruzi | Chagas disease (American trypanosomiasis) |
Plasmodium species[DAGGER] | Malaria |
Positive Fungal Cultures or Direct Examinations | |
Result | Reportable Disease Condition |
Any fungus in CSF | Fungal meningitis |
Positive Viral Cultures or Direct Examinations | |
Result | Reportable Disease Condition |
Any virus in CSF | Viral meningitis |
Arboviral agents including but not limited to: | |
California encephalitis virus | California encephalitis virus |
Chikungunya virus | Chikungunya virus |
Dengue virus, serotype 1, 2, 3, or 4 | Dengue |
Eastern equine encephalomyelitis virus | Eastern equine encephalitis (EEE) virus |
LaCrosse encephalitis virus | LaCrosse encephalitis virus |
St. Louis encephalitis virus | St. Louis encephalitis (SLE) virus |
Western equine encephalomyelitis virus | Western equine encephalitis (WEE) virus |
West Nile virus | West Nile encephalitis (WNV) virus |
Zika virus | Zika virus |
Arena viruses | Viral hemorrhagic fevers |
Poliovirus, type 1, 2, or 3 | Poliomyelitis |
Filoviruses | Viral hemorrhagic fevers |
Varicella virus | Varicella in patients > 15 years of age |
Any SARS-CoV-S laboratory result | SARS-CoV-2 |
Variola virus | Smallpox |
Yellow fever virus | Yellow fever |
Positive Blood Chemistries | |
Blood lead levels (venous) of >= 5µg/dL in patients <=6 years of age | |
Positive Toxin Identification | |
Ricin toxin from Ricinus communis (castor beans) | |
Surgical Pathology Results | |
Creutzfeldt-Jakob Disease, including new variant | |
Hansen disease (Mycobacterium leprae) | |
Human rabies | |
Malignant Neoplasms | |
Mycobacterial disease including Tuberculosis | |
Trichinosis | |
Miss. Code. tit. 15, pt. 2, subpt. 11, ch. 1, subch. 19, Appendices to the Rules and Regulations Governing Reportable Diseases and Conditions, app 15-2-11-1-19-B